|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3350 EUR | -1.76% |
|
+5.83% | +25.00% |
| 07-01 | Nicox Submits NCX 470 New Drug Application In The United States | CI |
| 07-01 | Nicox files U.S. marketing approval application |  |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- ALCOX Stock
- NXOA Stock
- Consensus Nicox SA
- Estimates Revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
